Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000897069-25-001036
Filing Date
2025-05-27
Accepted
2025-05-27 16:14:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 6514
  Complete submission text file 0000897069-25-001036.txt   8268
Mailing Address WALLSTRASSE 16 BERLIN 2M 10179
Business Address WALLSTRASSE 16 BERLIN 2M 10179 49 89 2153 9035
ATAI Life Sciences N.V. (Subject) CIK: 0001840904 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-93405 | Film No.: 25988533
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 107 GRAND ST. 7TH FLOOR NEW YORK NY 10013
Business Address 107 GRAND ST. 7TH FLOOR NEW YORK NY 10013 (212) 390-9195
Galaxy Group Funding ECI U LLC (Filed by) CIK: 0001914073 (see all company filings)

EIN.: 862298090 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A